Issue 3/1997
Content (9 Articles)
High-mobility-group proteins and cancer—an emerging link
Volker Wunderlich, Michael Böttger
DNA adducts in human placenta in relation to tobacco smoke exposure and plasma antioxidant status
Helmut Daube, Gerhard Scherer, Kirsten Riedel, Thomas Ruppert, Anthony R. Tricker, Peter Rosenbaum, Franz Adlkofer
Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells
Yael Zimra, Lina Wasserman, Lea Maron, Mati Shaklai, Abraham Nudelman, Ada Rephaeli
Expression of epidermal growth factor receptor in gestational trophoblastic diseases
Prabha Balaram, Molykutty John, T. N. Rajalekshmy, Balaraman Nair, Gregory Schultz, Krishnan Nair
Serum levels of interleukins, growth factors and anglogenin in patients with endometrial cancer
Vimlarani Chopra, Tung V. Ding, Edward V. Hanningan
Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trial
Barbara D. Wamil, Gary B. Thurman, Hakan W. Sundell, Russel F. DeVore, Gail Wakefield, David H. Johnson, Yue-Fen Wang, Carl G. Hellerqvist
Surgical therapy for localized prostatic carcinoma
Joachim Noldus, Peter Hammerer, Markus Graefen, Hartwig Huland
32nd Annual Meeting of the American Society of Clinical Oncology 18–21 May 1996, Philadelphia, Pennsylvania, USA
Maurie Markman
Intraarterial hepatic chemotherapy with fluorouracil, fluorodeoxyuridine, mitomycin C, cisplatin or methotrexate as single-agent anticancer drugs for a transplanted experimental liver tumor in rats
S. Kurth, D. Bulian, B. Kreft, Th. Riemenschneider